tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BBIO Stock Latest News

BridgeBio Pharma Strengthens Financial Position with Note Issuance
Company AnnouncementsBridgeBio Pharma Strengthens Financial Position with Note Issuance
4d ago
8K
BBIO
BridgeBio price target raised to $46 from $45 at BofA
PremiumThe Fly
BridgeBio price target raised to $46 from $45 at BofA
4d ago
BBIO
Strong Launch and Strategic Initiatives Propel BridgeBio Pharma’s Growth Prospects
PremiumRatings
Strong Launch and Strategic Initiatives Propel BridgeBio Pharma’s Growth Prospects
7d ago
BBIO
Positive Outlook for BridgeBio Pharma: Strong Demand for Attruby and Promising Pipeline Fuel Buy Rating
PremiumRatings
Positive Outlook for BridgeBio Pharma: Strong Demand for Attruby and Promising Pipeline Fuel Buy Rating
9d ago
BBIO
BridgeBio price target raised to $52 from $49 at Scotiabank
PremiumThe Fly
BridgeBio price target raised to $52 from $49 at Scotiabank
11d ago
BBIO
BridgeBio price target raised to $67 from $58 at Wells Fargo
PremiumThe FlyBridgeBio price target raised to $67 from $58 at Wells Fargo
11d ago
BBIO
BridgeBio price target raised to $49 from $45 at Citi
Premium
The Fly
BridgeBio price target raised to $49 from $45 at Citi
11d ago
BBIO
Positive Outlook for BridgeBio Pharma Due to Accelerating Patient Growth and Promising Drug Pipeline
Premium
Ratings
Positive Outlook for BridgeBio Pharma Due to Accelerating Patient Growth and Promising Drug Pipeline
11d ago
BBIO
BridgeBio Pharma Reports Strong 2024 Financial Results
PremiumCompany Announcements
BridgeBio Pharma Reports Strong 2024 Financial Results
11d ago
BBIO
BridgeBio Pharma’s Growth Potential and Strategic Positioning: A Buy Recommendation by Tyler Van Buren
PremiumRatings
BridgeBio Pharma’s Growth Potential and Strategic Positioning: A Buy Recommendation by Tyler Van Buren
12d ago
BBIO
BridgeBio price target raised to $95 from $70 at Cantor Fitzgerald
PremiumThe Fly
BridgeBio price target raised to $95 from $70 at Cantor Fitzgerald
12d ago
BBIO
BridgeBio reports Q4 EPS $1.40 vs. 96c last year
PremiumThe Fly
BridgeBio reports Q4 EPS $1.40 vs. 96c last year
12d ago
BBIO
Bridgebio Pharma (BBIO) Q4 Earnings Cheat Sheet
PremiumPre-EarningsBridgebio Pharma (BBIO) Q4 Earnings Cheat Sheet
14d ago
BBIO
BridgeBio Pharma’s European Approval of Acoramidis and Strong Pipeline Justifies Buy Rating
Premium
Ratings
BridgeBio Pharma’s European Approval of Acoramidis and Strong Pipeline Justifies Buy Rating
19d ago
BBIO
BridgeBio Pharma: EU Approval of Beyonttra Boosts Financial Stability and Supports U.S. Launch of Attruby
Premium
Ratings
BridgeBio Pharma: EU Approval of Beyonttra Boosts Financial Stability and Supports U.S. Launch of Attruby
19d ago
BBIO
BridgeBio price target raised to $49 from $48 at Scotiabank
PremiumThe Fly
BridgeBio price target raised to $49 from $48 at Scotiabank
20d ago
BBIO
BridgeBio announces EC marketing authorization for BETONTTRA
PremiumThe Fly
BridgeBio announces EC marketing authorization for BETONTTRA
21d ago
BBIO
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
PremiumThe Fly
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
2M ago
BBIO
BridgeBio Pharma Reports Strong Drug Uptake and Trial Progress
PremiumCompany Announcements
BridgeBio Pharma Reports Strong Drug Uptake and Trial Progress
2M ago
8K
BBIO
JPMorgan ‘very encouraged’ by initial Attruby metrics presented by BridgeBio
PremiumThe FlyJPMorgan ‘very encouraged’ by initial Attruby metrics presented by BridgeBio
2M ago
BBIO
BridgeBio announces commercial progress, pipeline updates
Premium
The Fly
BridgeBio announces commercial progress, pipeline updates
2M ago
BBIO
3 Best Stocks to Buy Now, 12/24/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 12/24/2024, According to Top Analysts 
2M ago
BKR
BBIO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >